Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02228642 · ClinicalTrials.gov registry record

Hypoglycemia in Hospitalized Patients

A clinical trial of Diabetes and Hypoglycemia, sponsored by University of Pittsburgh.

Completed
Registry status
58
Enrollment target
1
Study location

NCT02228642 is a study of Diabetes and Hypoglycemia that has completed, run by University of Pittsburgh. The registered enrollment target is 58 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02228642, a study of Diabetes and Hypoglycemia, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
58 participants
Enrollment target
1
Study location

Study Summary

Patients with diabetes who develop low blood sugars (hypoglycemia) in the hospital are at risk for losing the ability to develop symptoms that warn them that they are having a low blood sugar. There is almost no available information investigating how the inability to feel symptoms of a low blood sugar contributes to the risk of this happening when people with diabetes are hospitalized. The purpose of this study is to develop a symptom score model that will help to identify patients at risk for low blood sugars in the hospital and to examine what happens to patients who do experience a low blood sugar in the hospital.

Conditions Studied

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Medical Center PUH SSY - Pittsburgh

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2014-08
Est. Completion 2016-03

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02228642

The ClinicalTrials.gov registry entry for NCT02228642 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 0 interventions.

NCT02228642 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02228642 about?

NCT02228642 is a clinical study titled "Hypoglycemia in Hospitalized Patients". Patients with diabetes who develop low blood sugars (hypoglycemia) in the hospital are at risk for losing the ability to develop symptoms that warn them that they are having a low blood sugar. There is almost no available information investigating how the inability to feel symptoms of a low blood su...

What is the current status of trial NCT02228642?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2014-08. Estimated completion is 2016-03.

What conditions does trial NCT02228642 study?

This clinical trial studies the following conditions: Diabetes, Hypoglycemia.

Who is sponsoring clinical trial NCT02228642?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02228642 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.